SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HMSC- A simple breast cancer screening device
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: (no name provided) who wrote (68)3/3/1998 7:38:00 PM
From: FCC  Read Replies (3) of 246
 
The timing of your short is off. The stock will go through a period of profit taking but when?

Here is the problems with your thoughts:

1. The reason that the product is not reimbursed at this time is because it had come to the market first. A OB-GYN friend of mine told me this fact. By the way Traveller's insurance comp. owns a stake in HMSC.

2.This product was never meant to replace mammograms, but to supplement them. This technology is more sensitive than mammos, and palpation of the breast by the doctor. This product is meant to be the earliest detection device for breast cancer, is they find a developing tumor the pt has a greater chance for survival.

3. The product cost only $40. Very inexpensive as compared to other tests. The doctors are charged $25 and make a small profit.

4. Any doctor who doesnt offer this test,even if it doesn't work for all patients will one day get a letter from the lawyers office wondering why their client was not given the opportunity to possibly catch the malignancy at an earlier reversible stage.

5. Patient has nothing to lose, to try a painless, radiation less, inexpensive, speedy test. The time that the women must wait to here results from mammos seems like an eternity.

6. No one knows how well this product works, that's why they are doing the clinical trials. They have made changes in the product before shipping. The reason for the delay was that the product gave a false reading if it was shipped to very warm climate. That has all been rectified.

This is a very emotional area. We are dealing with potential blockbuster diagnostic tool.

Vivus made a lot of money for the people timed the buys and sells correctly.By the way they can't keep the product on the shelf, it sells out of the box. There are more women that need this breast alert, than men who need vivus' help.

GOOD LUCK TO THE LONGS!!!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News